Low-grade intraosseous osteosarcoma of the jaws.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod

Department of Oral Pathology, Medunsa Oral Health Centre, Medical University of Southern Africa, Pretoria, South Africa.

Published: July 1998

Two cases of low-grade intraosseous osteosarcomas are reported, bringing the total number of such osteosarcomas in the jawbones documented in recent literature to six. Our first case involved the maxilla of a 69-year-old man and the second involved the mandible of an 18-year-old girl. In clinical and microscopic appearance, these neoplasms resemble benign proliferations in many respects. Subtle differences include cortical bone destruction, soft tissue infiltration, irregular bone production with foci of abundant osteoid, and mild cellular atypia. Complete removal at the first attempt is of paramount importance, inasmuch as a significant percentage of these neoplasms recur as high-grade osteosarcomas if they are inadequately treated.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1079-2104(98)90154-8DOI Listing

Publication Analysis

Top Keywords

low-grade intraosseous
8
intraosseous osteosarcoma
4
osteosarcoma jaws
4
jaws cases
4
cases low-grade
4
intraosseous osteosarcomas
4
osteosarcomas reported
4
reported bringing
4
bringing total
4
total number
4

Similar Publications

Mucoepidermoid carcinoma (MEC) is the most common malignant tumor of salivary glands.It usually occurs in major salivary glands. The occurrence of intraosseous MEC (IMEC) is rare and is usually seen in the mandibular premolar and molar regions.

View Article and Find Full Text PDF

Intraosseous mucoepidermoid carcinoma of the mandible.

Ecancermedicalscience

September 2023

Alexander Fleming Cancer Institute, Pathological Anatomy Service, 1180 Cramer, Buenos Aires 3201, Argentina.

Background: Mucoepidermoid carcinoma starts in the salivary glands and accounts for 5%-10% of all salivary gland tumours. Its intraosseous occurrence is rare and only accounts for 2%-3% of all mucoepidermoid carcinomas. This neoplasm often follows a long and indolent course.

View Article and Find Full Text PDF
Article Synopsis
  • This text discusses mesenchymal spindle cell tumors with kinase fusions, which are rare bone tumors primarily found in younger patients, and that have different genetic markers.
  • A study analyzed eight cases of these tumors alongside seven previously reported cases, finding a majority in the head and neck area of young patients with various kinase fusions.
  • The tumors generally showed high-grade malignancy, especially those with NTRK3 fusions, while others exhibited low-grade traits, and some tumors in older patients presented with aggressive characteristics.
View Article and Find Full Text PDF

Introduction: Enchondromas and grade 1 chondrosarcomas are commonly encountered low-grade chondroid tumors in the proximal humerus. While there is a concern for malignant transformation, few studies have evaluated the natural history of these lesions. The purpose of this study is to evaluate the natural history of proximal humerus low-grade chondroid lesions managed both conservatively and surgically, and to define management criteria using clinical and radiographic findings for these low-grade chondroid lesions.

View Article and Find Full Text PDF

Is a radiological score able to predict resection-grade chondrosarcoma in primary intraosseous lesions of the long bones?

Bone Joint J

July 2023

University Musculoskeletal Oncology Unit, Division of Orthopaedic Surgery, Department of Surgery, Mount Sinai Hospital, University of Toronto, Toronto, Canada.

Aims: The preoperative grading of chondrosarcomas of bone that accurately predicts surgical management is difficult for surgeons, radiologists, and pathologists. There are often discrepancies in grade between the initial biopsy and the final histology. Recent advances in the use of imaging methods have shown promise in the ability to predict the final grade.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!